The latest closing stock price for Monte Rosa Therapeutics as of March 28, 2025 is 5.10.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-759 today, roughly -1 times their original investment - a -29.95% compound annual growth rate over 4 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 12.40, which is 143.1% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 3.21, which is 37.1% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 5.95.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-759 today, roughly -1 times their original investment - a -29.95% compound annual growth rate over 4 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 12.40, which is 143.1% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 3.21, which is 37.1% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 5.95.